Rare diseases
Investigational molecules
Locations
703 conditions with trials, the busiest first
3 898 trials across Europe, recruiting first
Study on Acetylsalicylic Acid for Colorectal Cancer Patients with PI3K Pathway Mutations
DenmarkStudy Comparing Two Cisplatin Dosing Schedules with Radiation for Patients with Advanced Head and Neck Cancer
IrelandStudy of Spartalizumab and Pazopanib for Patients with Refractory or Recurrent Solid Tumors
FranceStudy on the Effectiveness of Floxuridine in Patients with Resectable Colorectal Liver Metastases and Low Clinical Risk Score
The NetherlandsStudy of Bemarituzumab with Irinotecan, Paclitaxel, Ramucirumab, or Trifluridine/Tipiracil for Advanced Stomach or Gastroesophageal Cancer in Patients After Chemotherapy
GermanyStudy on the Safety and Effectiveness of Peginterferon Alfa-2a and Ruxolitinib for Newly Diagnosed Polycythemia Vera Patients
DenmarkStudy on the Treatment of Warthin's Tumor with Bleomycin Sclerotherapy for Patients with Warthin's Tumor
FinlandStudy on Darolutamide, Triptorelin, and Leuprorelin Acetate for Patients with Newly Diagnosed Prostate Cancer and Pelvic Lymph Node Metastases
FranceStudy of ixazomib, iberdomide and dexamethasone combination in elderly patients with first relapse of multiple myeloma
FranceStudy of Durvalumab with Thoracic Radiotherapy and Chemotherapy for Patients with Extensive Stage Small Cell Lung Cancer After Initial Treatment
ItalyStudy on Maintenance Therapy with OSE2101 and FOLFIRI for Patients with Advanced Pancreatic Cancer After Initial FOLFIRINOX Treatment
FranceStudy Comparing Short-Course and Long-Course Chemotherapy with mFOLFIRINOX or PAXG for Patients with Stage I-III Pancreatic Cancer
ItalyThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
